Epigenetic Mechanisms of T Cell Dysregulation in PTSD
PTSD 中 T 细胞失调的表观遗传机制
基本信息
- 批准号:9217144
- 负责人:
- 金额:$ 48.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-11-15 至 2021-10-31
- 项目状态:已结题
- 来源:
- 关键词:AfghanistanAttentionAutoimmune DiseasesCalcineurinCellsCellular StructuresCellular biologyClinical Course of DiseaseCodeDNA MethylationDNA SequenceDiagnosisDiseaseDomestic ViolenceEarly DiagnosisEarly treatmentEpigenetic ProcessEventExhibitsExposure toFamily memberFreedomGene ExpressionGenesGoalsHealthHigh PrevalenceHydrocortisoneImmuneImmune responseImmunologicsIn VitroIncidenceIndividualInflammationInflammatoryInflammatory ResponseInterleukin-17IraqLeadLifeMental disordersMessenger RNAMethylationMicroRNAsModificationNeighborhoodsNeurodegenerative DisordersNucleic Acid Regulatory SequencesPPP3CA genePPP3CC genePPP3R2 genePathway interactionsPatientsPeripheral Blood Mononuclear CellPhosphorylationPlayPopulation StudyPost-Traumatic Stress DisordersPrevalenceProtein DephosphorylationProtein IsoformsProtein phosphataseProteinsRegulationReportingRoleSerineSeveritiesSignal PathwaySignal TransductionSymptomsT cell differentiationT cell regulationT cell responseT-Cell ProliferationT-LymphocyteTestingThreonineTransfectionTraumaVariantVeteransWarWomanbasecalcineurin phosphatasecardiovascular disorder riskchromatin remodelingcombatcytokinedisorder controlepigenetic markerepigenetic regulationepigenomicsgenome-widehigh riskhistone methylationhistone modificationimmune functionimmunoregulationinhibitor/antagonistmenmethylation patternnuclear factors of activated T-cellsoperationtranscription factortraumatic eventurban area
项目摘要
Post-traumatic stress disorder (PTSD) is an adverse psychiatric condition that occurs after
exposure to extremely stressful life events. PTSD patients also develop a variety of disorders
with an inflammatory component. While majority of the studies indicate that there is an
excessive inflammatory state in PTSD, the precise mechanisms of immunomodulation seen
during PTSD are not clear. Recently, we have made an exciting observation that the severity of
PTSD is correlated with greater inflammation and a broadly dysregulated microRNA (miR)
profile with numerous targets that regulate inflammatory T cell response. Specifically, we noted
that numerous downregulated miRs in PTSD patients targeted components of the nuclear factor
of activated T cells (NFAT) pathway, crucial for the activation, proliferation and differentiation of
T cells. In addition to the NFAT proteins themselves, the serine-threonine protein phosphatase
calcineurin subunits A (isoforms PPP3CA, PPP2CB, and PPP3CC) and B (isoforms PPP3R1
and PPP3R2), which activate NFAT through dephosphorylation, were found to serve as targets
for numerous dysregulated miRs in PTSD patients. The status of the T cell regulation, and in
particular, the NFAT pathway in PTSD has not been evaluated thus far. Based on our
preliminary studies, we will test the central hypothesis that PTSD associates, at least in
part, with dysregulation in the epigenetic mechanisms that alter NFAT signaling pathway
leading to a pro-inflammatory state. We will pursue these studies trauma-exposed PTSD
patients when compared to trauma-exposed non-PTSD controls. We will pursue 3 specific aims:
Aim 1: We will identify the mechanisms through which miR dysregulation leads to alterations in
NFAT signaling pathway leading to an inflammatory state in PTSD patients. Aim 2: We will
determine whether PTSD triggers differential DNA methylation of specific miR and/or targets of
NFAT signaling pathway components in T cells leading to pro-inflammatory response. Aim 3:
We will test the role of histone modifications in the expression of miRs on NFAT components in
PTSD patients.
Together, our studies will delineate the epigenetic mechanisms underlying signaling
pathways that lead to alterations in NFAT signaling and consequent T cell dysregulation and
excess inflammation in PTSD patients. Our studies also aim to identify epigenetic biomarkers of
PTSD that will help in the early diagnosis and treatment.
创伤后应激障碍(PTSD)是一种不良精神病病,发生在
暴露于极大的生活事件。 PTSD患者还会出现多种疾病
具有炎症成分。大多数研究表明有一个
PTSD中的过度炎症状态,这是免疫调节的确切机制
在PTSD期间尚不清楚。最近,我们对
PTSD与更大的炎症和宽阔失调的microRNA相关(miR)
具有调节炎症T细胞反应的众多靶标的轮廓。具体来说,我们指出
在PTSD患者中,许多下调MIR针对核因子的成分
活化的T细胞(NFAT)途径,对于激活,增殖和分化至关重要
T细胞。除NFAT蛋白本身外,丝氨酸 - 硫代蛋白磷酸酶
钙调神经酶亚基A(同工型PPP3CA,PPP2CB和PPP3CC)和B(同工型PPP3R1
发现通过去磷酸化激活NFAT的PPP3R2)被发现用作目标
对于PTSD患者的许多失调MIR。 T细胞调节的状态和
特别是,迄今为止尚未评估PTSD中的NFAT途径。基于我们
初步研究,我们将测试中心假设,即PTSD同伴,至少在
部分,具有改变NFAT信号通路的表观遗传机制的失调
导致促炎性状态。我们将继续进行这些研究暴露于创伤的PTSD
与暴露于创伤的非PTSD对照相比,患者。我们将追求3个具体目标:
目标1:我们将确定miR失调导致改变的机制
NFAT信号通路导致PTSD患者的炎症状态。目标2:我们将
确定PTSD是否触发特定miR和/或靶标的差异DNA甲基化
T细胞中的NFAT信号通路成分导致促炎反应。目标3:
我们将测试组蛋白修饰在miR表达中的作用在NFAT成分中
PTSD患者。
总之,我们的研究将描述信号传导的表观遗传机制
导致NFAT信号传导改变以及随之而来的T细胞失调和
PTSD患者过多的炎症。我们的研究还旨在确定
PTSD将有助于早期诊断和治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mitzi Nagarkatti其他文献
Mitzi Nagarkatti的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mitzi Nagarkatti', 18)}}的其他基金
Targeting early ceramide elevation in pre-symptomatic eczema
针对症状前湿疹的早期神经酰胺升高
- 批准号:
10665481 - 财政年份:2022
- 资助金额:
$ 48.38万 - 项目类别:
Silybin as an anti-inflammatory and anti-fibrotic agent in cancer cachexia
水飞蓟宾作为癌症恶病质的抗炎和抗纤维化剂
- 批准号:
10665485 - 财政年份:2022
- 资助金额:
$ 48.38万 - 项目类别:
Role of the environmental sensor, AhR on colitis
环境传感器 AhR 对结肠炎的作用
- 批准号:
10390988 - 财政年份:2021
- 资助金额:
$ 48.38万 - 项目类别:
Role of the environmental sensor, AhR on colitis
环境传感器 AhR 对结肠炎的作用
- 批准号:
10494130 - 财政年份:2021
- 资助金额:
$ 48.38万 - 项目类别:
Role of the environmental sensor, AhR on colitis
环境传感器 AhR 对结肠炎的作用
- 批准号:
10757110 - 财政年份:2021
- 资助金额:
$ 48.38万 - 项目类别:
Role of the environmental sensor, AhR on colitis
环境传感器 AhR 对结肠炎的作用
- 批准号:
10685372 - 财政年份:2021
- 资助金额:
$ 48.38万 - 项目类别:
Role of the environmental sensor, AhR on colitis
环境传感器 AhR 对结肠炎的作用
- 批准号:
10774364 - 财政年份:2021
- 资助金额:
$ 48.38万 - 项目类别:
Epigenetic mechanisms in Transgenerational Effects of an Environmental Pollutant
环境污染物跨代效应的表观遗传机制
- 批准号:
10440259 - 财政年份:2019
- 资助金额:
$ 48.38万 - 项目类别:
Epigenetic mechanisms in Transgenerational Effects of an Environmental Pollutant
环境污染物跨代效应的表观遗传机制
- 批准号:
10023261 - 财政年份:2019
- 资助金额:
$ 48.38万 - 项目类别:
Epigenetic mechanisms in Transgenerational Effects of an Environmental Pollutant
环境污染物跨代效应的表观遗传机制
- 批准号:
10658858 - 财政年份:2019
- 资助金额:
$ 48.38万 - 项目类别:
相似国自然基金
逆全球化下跨国企业动态能力形成的微观机理研究:高管注意力配置视角
- 批准号:72302220
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人机共驾模式下驾驶人监管注意力弱化-恢复规律与调控机理
- 批准号:52302425
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
注意力感知驱动的车载多模态传感器在线协同校正
- 批准号:42301468
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于两阶段注意力深度学习方法的系统性金融风险测度与预警研究
- 批准号:72301101
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Cytokine Regulation of Secondary Neural Progenitors
次级神经祖细胞的细胞因子调节
- 批准号:
10752901 - 财政年份:2023
- 资助金额:
$ 48.38万 - 项目类别:
The Protective and Pathologic Features of the EVD Survivor Immune System
埃博拉病毒病幸存者免疫系统的保护和病理特征
- 批准号:
10639583 - 财政年份:2023
- 资助金额:
$ 48.38万 - 项目类别:
Does the Maternal Environment During Viral Infection and Inflammation Direct Fetal Gamma Delta T Cell Development and Function?
病毒感染和炎症期间的母体环境是否直接影响胎儿 Gamma Delta T 细胞的发育和功能?
- 批准号:
10840234 - 财政年份:2023
- 资助金额:
$ 48.38万 - 项目类别:
Influence of the Microbiome on the Natural History of Alopecia Areata
微生物组对斑秃自然史的影响
- 批准号:
10585677 - 财政年份:2023
- 资助金额:
$ 48.38万 - 项目类别:
R-5280, A Novel Modified Superior Resistant Starch Therapy for Type 1 Diabetes
R-5280,一种针对 1 型糖尿病的新型改良优质抗性淀粉疗法
- 批准号:
10759268 - 财政年份:2023
- 资助金额:
$ 48.38万 - 项目类别: